<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               4 CONTRAINDICATIONS<BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           Patients with a known hypersensitivity to the drug or to any of the excipients (4.1).<BR>                           Women of premenopausal endocrine status, including pregnant women (4.2).<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     4.1  Hypersensitivity<BR>                     <BR>                        AROMASIN Tablets are contraindicated in patients with a known hypersensitivity to the drug or to any of the excipients.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     4.2  Pregnancy<BR>                     <BR>                        AROMASIN may cause fetal harm when administered to a pregnant woman. Based on its mechanism of action AROMASIN is expected to result in adverse reproductive effects.  In non-clinical studies in rats and rabbits, exemestane was embryotoxic, fetotoxic, and abortifacient.<BR>                        AROMASIN is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.<BR>                        AROMASIN Tablets should not be administered to premenopausal women [see Use in Specific Populations (8.1)].<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>